Abstract:Rationale: SUMOylation regulates a plethora of biological processes, and its inhibitors are currently under investigation in clinical trials as anticancer agents. Thus, identifying new targets with site-specific SUMOylation and defining their biological functions will not only provide new mechanistic insights into the SUMOylation signaling but also open an avenue for developing new strategy for cancer therapy. MORC family CW-type zinc finger 2 (MORC2) is a newly identified chromatin-remodeling enzyme with an emerging role in the DNA damage response (DDR), but its regulatory mechanism remains enigmatic. Methods: In vivo and in vitro SUMOylation assays were used to determine the SUMOylation levels of MORC2. Overexpression and knockdown of SUMO-associated enzymes were used to detect their effects on MORC2 SUMOylation. The effect of dynamic MORC2 SUMOylation on the sensitivity of breast cancer cells to chemotherapeutic drugs was examined through in vitro and in vivo functional assays. Immunoprecipitation, GST pull-down, MNase, and chromatin segregation assays were used to explore the underlying mechanisms. Results: Here, we report that MORC2 is modified by small ubiquitin-like modifier 1 (SUMO1) and SUMO2/3 at lysine 767 (K767) in a SUMO-interacting motif dependent manner. MORC2 SUMOylation is induced by SUMO E3 ligase tripartite motif containing 28 (TRIM28) and reversed by deSUMOylase sentrin-specific protease 1 (SENP1). Intriguingly, SUMOylation of MORC2 is decreased at the early stage of DNA damage induced by chemotherapeutic drugs that attenuate the interaction of MORC2 with TRIM28. MORC2 deSUMOylation induces transient chromatin relaxation to enable efficient DNA repair. At the relatively late stage of DNA damage, MORC2 SUMOylation is restored, and SUMOylated MORC2 interacts with protein kinase CSK21 (casein kinase II subunit alpha), which in turn phosphorylates DNA-PKcs (DNA-dependent protein kinase catalytic subunit), thus promoting DNA repair. Notably, expression of a SUMOylation-deficient mutant MORC2 or administration of SUMO inhibitor enhances the sensitivity of breast cancer cells to DNA-damaging chemotherapeutic drugs. Conclusions: Collectively, these findings uncover a novel regulatory mechanism of MORC2 by SUMOylation and reveal the intricate dynamics of MORC2 SUMOylation important for proper DDR. We also propose a promising strategy to sensitize MORC2-driven breast tumors to chemotherapeutic drugs by inhibition of the SUMO pathway.

SUMOylation Stabilizes Hssb1 and Enhances the Recruitment of NBS1 to DNA Damage Sites

USP37 Regulates DNA Damage Response Through Stabilizing and Deubiquitinating BLM

Acetylation-dependent Function of Human Single-Stranded DNA Binding Protein 1

Functional Characterization of TIP60 Sumoylation in UV-irradiated DNA Damage Response.

SUMO-1 Modification of FEN1 Facilitates Its Interaction with Rad9-Rad1-Hus1 to Counteract DNA Replication Stress

USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response

hSSB1 regulates both the stability and the transcriptional activity of p53

SUMOylation of HNRNPA2B1 Modulates RPA Dynamics During Unperturbed Replication and Genotoxic Stress Responses.

Sumoylation of MDC1 is important for proper DNA damage response

A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.

Crosstalk Between SUMOylation and Ubiquitylation Controls DNA End Resection by Maintaining MRE11 Homeostasis on Chromatin

FBXL5-mediated Degradation of Single-Stranded DNA-binding Protein Hssb1 Controls DNA Damage Response.

USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

Succinylation at a Key Residue of FEN1 is Involved in the DNA Damage Response to Maintain Genome Stability

USP39 Regulates DNA Damage Response and Chemo-Radiation Resistance by Deubiquitinating and Stabilizing CHK2.

SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer.

Sumoylation Influences DNA Break Repair Partly by Increasing the Solubility of a Conserved End Resection Protein.

SUMOylation of PTEN promotes DNA end resection through directly dephosphorylating 53BP1 in homologous recombination repair

The SUMO-NIP45 pathway processes toxic DNA catenanes to prevent mitotic failure

Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer

A Selective USP1–UAF1 Inhibitor Links Deubiquitination to DNA Damage Responses